(MedPage Today) -- In this exclusive video ahead of the upcoming San Antonio Breast Cancer Symposium (SABCS), Leif W. Ellisen, MD, PhD, of Harvard Medical School and Massachusetts General Hospital in Boston, previews his session on…
(MedPage Today) -- Despite recent progress in understanding the disease, inflammatory breast cancer (IBC) remains a challenge to diagnose and treat, and the prognosis remains worse than for breast cancer in general.
(MedPage Today) -- In 2023, the FDA updated its mammography regulations, with a key amendment that required facilities to provide information to patients regarding the density of their breasts.
Two years after she was diagnosed with stage 2 breast cancer, the 53-year-old actress said she was 'rocking out and celebrating' after receiving new test results from her doctor.
Breast cancer is able to modify the lymphatic vessels through which it travels to the draining lymph nodes. From there, it can then spread to other parts of the body.
The Professional Women's Hockey League community came together Tuesday to support the Ottawa Charge's beloved head coach Carla MacLeod in her battle with breast cancer.
Breast cancer is able to modify the lymphatic vessels through which it travels to the draining lymph nodes. From there, it can then spread to other parts of the body. A new finding by Finnish researchers may help develop targeted therapies…
For years follow-up tests and monitoring were not carried out after inconclusive mammograms, sparking fears that falsely reassured patients may have unknowingly developed cancer.
(MedPage Today) -- Women younger than 50 accounted for about a quarter of all breast cancers diagnosed at a large community imaging practice in New York, with a substantial number in women under age 40, a retrospective review found.
The Federal Circuit in a precedential opinion Tuesday reversed a $41.8 million verdict against Daiichi Sankyo for infringing a Seagen breast cancer treatment patent, saying a lower court should have found that the patent didn't adequately…
Findings from a preclinical study demonstrate that Omomyc—the only direct MYC inhibitor to have successfully completed a phase I clinical trial—causes DNA damage in cancer cells which is synergistically enhanced in combination with poly …
A cancer-targeting antibody that helps the body's immune cells spot and destroy hard-to-treat tumors such as triple-negative breast cancer has been developed by researchers.
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in post-menopausal women with obesity.
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal women with obesity. It also raises the…